[Effect of Selinexor on Proliferation and Apoptosis of Acute Myeloid Leukemia Kasumi-1 Cells]

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Aug;32(4):1085-1090. doi: 10.19746/j.cnki.issn.1009-2137.2024.04.017.
[Article in Chinese]

Abstract

Objective: To investigate the effects of selinexor, a inhibitor of nuclear export protein 1 (XPO1) on the proliferation inhibition and apoptosis of Kasumi-1 cells in acute myeloid leukemia (AML).

Methods: MTS method was used to detect the inhibitory effect of different concentrations of selinexor on the proliferation of Kasumi-1 cells at different time points. The apoptosis rate and cell cycle changes after treatment with different concentration of selinexor were detected by flow cytometry.

Results: Selinexor inhibited the growth of Kasumi-1 cells at different time points in a concentration-dependent manner (r 24 h=0.7592, r 48 h=0.9456, and r 72 h=0.9425). Selinexor inhibited Kasumi-1 cells growth in a time-dependent manner (r =0.9057 in 2.5 μmol/L group, r =0.9897 in 5 μmol/L group and r =0.9994 in 10 μmol/L group). Selinexor could induce apoptosis of Kasumi-1 cells in a dose-dependent manner (r =0.9732), and the apoptosis of Kasumi-1 cells was more obvious with the increase of drug concentration. The proportion of G0/G1 phase was significantly increased and the proportion of S phase was significantly decreased after the treatment of Kasumi-1 cells by selinexor. With the increase of drug concentration, the proportion of Kasumi-1 cells cycle arrest in G0/G1 phase was increased and the cell synthesis was decreased.

Conclusion: Selinexor can promote the death of tumor cells by inhibiting Kasumi-1 cells proliferation, inducing apoptosis and blocking cell cycle.

题目: XPO1抑制剂塞利尼索对急性髓系白血病Kasumi-1细胞增殖和凋亡的影响.

目的: 探讨核输出蛋白1(XPO1)抑制剂塞利尼索对急性髓系白血病(AML)Kasumi-1细胞增殖与凋亡的影响。.

方法: 用MTS法检测不同浓度塞利尼索(0、2.5、5、10 μmol/L)作用于Kasumi-1细胞不同时间点(24、48、72 h)的增殖抑制率;流式细胞术检测不同浓度塞利尼索作用于Kasumi-1细胞48 h后的细胞凋亡率和细胞周期变化情况。.

结果: 塞利尼索在不同时间点均可抑制Kasumi-1细胞生长,并呈浓度依赖(r 24 h=0.7592,r 48 h=0.9456,r 72 h=0.9425);不同浓度塞利尼索均可抑制Kasumi-1细胞生长,并呈时间依赖(2.5 μmol/L组r =0.9057,5 μmol/L组r =0.9897,10 μmol/L组r =0.9994)。塞利尼索可诱导Kasumi-1细胞凋亡,且呈浓度依赖(r =0.9732),随着药物浓度的增大,诱导Kasumi-1细胞凋亡的作用越明显。塞利尼索作用于Kasumi-1细胞48 h后,G0/G1期细胞比例明显上升,S期细胞比例明显下降,并且随着塞利尼索药物浓度的增大,Kasumi-1细胞周期阻滞于G0 /G1期的细胞比例增加,细胞合成减少。.

结论: 塞利尼索可抑制Kasumi-1细胞增殖,诱导细胞凋亡,阻滞细胞周期于G0/G1期,导致肿瘤细胞的死亡。.

Keywords: XPO1; selinexor; kasumi-1 cells; proliferation; apoptosis.

Publication types

  • English Abstract

MeSH terms

  • Apoptosis* / drug effects
  • Cell Cycle / drug effects
  • Cell Line, Tumor
  • Cell Proliferation* / drug effects
  • Exportin 1 Protein
  • Humans
  • Hydrazines* / pharmacology
  • Karyopherins
  • Leukemia, Myeloid, Acute* / drug therapy
  • Triazoles* / pharmacology

Substances

  • selinexor
  • Hydrazines
  • Triazoles
  • Exportin 1 Protein
  • Karyopherins